Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| ALN-H52H9 | Human | Human Alpha-fetoprotein, His Tag (MALS verified) |  |
|
The purity of Human Alpha-fetoprotein, His Tag (Cat. No. ALN-H52H9) is more than 95% and the molecular weight of this protein is around 65-85 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| JWATM-203 | JWATM-203; JWATM203 | Phase 2 Clinical | Suzhou Yaomingjunuo Biotechnology Co Ltd | Carcinoma, Hepatocellular | Details |
| SynOV1.1 | Phase 2 Clinical | Beijing Syngentech Co Ltd | Solid tumours; Carcinoma, Hepatocellular | Details | |
| ET140203 | Phase 2 Clinical | Eureka Therapeutics Inc | Liver Neoplasms; Hepatoblastoma; Carcinoma, Hepatocellular | Details | |
| Alpha fetoprotein targeted T-cell therapy (Adaptimmune) | AFP TCR (ADP-A2AFP); ADP-A2AFP; AFP TCR; AFPc332T | Phase 1 Clinical | Adaptimmune Llc | Carcinoma, Hepatocellular | Details |
| HRYZ-T102 | HRYZ-T102 | Phase 1 Clinical | Hengrui Yuanzheng (Shanghai) Biotechnology Co Ltd | Solid tumours; Carcinoma, Hepatocellular | Details |
| TAEST-1901 | TAEST-1901 | Phase 1 Clinical | Xiangxue Life Science Technology (Guangdong) Co Ltd | Liver Neoplasms; Neoplasms | Details |
| ET1402L1-ARTEMIS T cells | Phase 1 Clinical | Aeon Therapeutics (Beijing) Co Ltd | Liver Neoplasms; Carcinoma, Hepatocellular | Details | |
| CPU-118 | CPU-118 | Phase 1 Clinical | China Pharmaceutical University, Nanjing Qinling Pharmaceutical Technology Co Ltd | Liver Neoplasms; Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
